Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Xiang Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5213-1905; OpenAlex author ID A5101912909. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis. First author DOI 10.3390/cancers16081540↗
  2. Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling. Co-author DOI 10.1016/j.phymed.2021.153861↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei‐Ming Wang · 2 shared papers, 2022–2024 · strength 0.43
  2. Zhenyan Pan · 1 shared paper, 2024 · strength 0.28
  3. Gang Chen · 1 shared paper, 2024 · strength 0.28
  4. Lingming Kong · 1 shared paper, 2024 · strength 0.28
  5. Xu Zheng · 1 shared paper, 2022 · strength 0.15
  6. Chunmei Wen · 1 shared paper, 2022 · strength 0.15
  7. Jie Deng · 1 shared paper, 2022 · strength 0.15
  8. Qingqing Ruan · 1 shared paper, 2022 · strength 0.15
  9. Yongheng Bai · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.